Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1

Conditions

Melanoma 5Ovarian Neoplasms 3Gliosarcoma 3Glioblastoma 3Central Nervous System Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Astrocytoma 3Uterine Neoplasms 2Uterine Cervical Neoplasms 2Sarcoma, Ewing 2Multiple Myeloma 2Lung Neoplasms 2Kidney Neoplasms 2Colorectal Neoplasms 2Colonic Neoplasms 2Carcinoma, Renal Cell 2Breast Neoplasms 2Brain Neoplasms 2Small Cell Lung Carcinoma 1Sarcoma 1Pancreatic Neoplasms 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive 1Neoplasms, Plasma Cell 1Neoplasms 1Mesothelioma, Malignant 1Meningioma 1Medulloblastoma 1Lymphoma, Follicular 1Lymphoma 1

Interventions

Melphalan 3sargramostim 1romidepsin 1montanide ISA 51 1keyhole-limpet hemocyanin 1detox adjuvant 1Ursodeoxycholic Acid 1Thalidomide 1Streptozocin 1Mercaptopurine 1Leucovorin 1Interleukin-2 1Floxuridine 1FANG vaccine 1Docetaxel 1Celecoxib 1Carmustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Genetic Diseases, Inborn × FANG vaccine × Clear all
NCT00019097 2024-03-04

Vaccine Therapy in Treating Patients With Multiple Myeloma

National Cancer Institute (NCI)

Phase 2 Completed
Other hematologic neoplasmPlasma cell

Multiple Myeloma, Neoplasms, Hematologic Neoplasms, Genetic Diseases, Inborn, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡